Todd Franklin Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), bought 6,038 shares at $1.69 ($21K) on 2024-05-31, disclosed to the SEC on 2024-12-03.
Seasonal purchase ($21k) by See Remarks — this insider has traded ARQT in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.69 | 4,000 | $7K | 31.8% |
| 2 | $7.11 | 2,038 | $14K | 68.2% |
| Total | $3.52 avg | 6,038 | $21K | 100% |
| Filing → |
| ARQT | SELL | 2025-03-20 | $21K | — | Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |